Clene Provides Update On Its NIH-Funded Expanded Access Program For CNM-Au8® In ALS (ACT-EAP)
Source: menafn.com
Clene Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Clene Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Clene Inc Today - Breaking & Trending Today
Benchmark Reiterates "Buy" Rating for Clene (NASDAQ:CLNN)
Benchmark restated their buy rating on shares of Clene (NASDAQ:CLNN – Free Report) in a report issued on Thursday morning, Benzinga reports. Benchmark currently has a $5.00 target price on the stock. Separately, HC Wainwright reissued a buy rating and set a $7.00 price objective on shares of Clene in a research note on Wednesday, […]
Source: theenterpriseleader.com
Clene (NASDAQ:CLNN) Stock Rating Reaffirmed by Benchmark
Benchmark reissued their buy rating on shares of Clene (NASDAQ:CLNN – Free Report) in a report issued on Thursday morning, Benzinga reports. Benchmark currently has a $5.00 price objective on the stock. Separately, HC Wainwright reiterated a buy rating and issued a $7.00 price target on shares of Clene in a research note on Wednesday, […]
Source: wkrb13.com
Bullish Clene Insiders Loaded Up On US$9.58m Of Stock
Quite a few insiders have dramatically grown their holdings in Clene Inc. ( NASDAQ:CLNN ) over the past 12 months. An...
Source: yahoo.com
Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights
Initiated discussions with FDA regarding accelerated approval pathway for CNM-Au8® for the treatment of ALS with the objective of submitting an NDA in 2024Released long-term data from the open-label extension
Source: eagletribune.com